Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and safety of satralizumab from two phase 3 trials in neuromyelitis optica spectrum disorder
Efficacy and safety of satralizumab from two phase 3 trials in neuromyelitis optica spectrum disorder
2020
Zdenka Haskova
Benjamin Frishberg
Jérôme De Seze
Brian G Weinshenker
Y Terada
Y Kawata
Athos Gianella-Borradori
Christian von Büdingen
Gaelle Klingelschmitt
Anthony Traboulsee
Takashi Yamamura
Keywords:
Biology
Dermatology
Anatomy
Spectrum disorder
Neuromyelitis optica
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]